Heidelberg Pharma AG (HPHA.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap134.41M
Enterprise Value120.59M
P/E Ratio-3.57
PEG Ratio0.06
Price/Sales Ratio15.71
Price/Book Ratio-8.23
Enterprise/Revenue12.37
Enterprise/EBITDA-2.97

Fiscal Year

Fiscal YearNovember 30, 2025
Most Recent QuarterMay 31, 2026

Profitability

Profit Margin-4.45
Operating Margin-4.58
AD

Management Effectiveness

Return On Assets-0.71
Return On Equity4.45

Income Statement

Revenue1.46M
Revenue/Share0.16
Gross Profit-1.19M
EBITDA-44.63M
Net Income-42.28M
Diluted EPS-0.91

Balance Sheet

Total Cash24.93M
Total Cash/Share0.53
Total Debt45,985
Total Debt/Equity-0
Current Ratio5.29
Book Value Per Share-0.3

Price History

52-Week Change-27.75
52-Week High3.61
52-Week Low2.33
Moving Average 50 Days2.55
Moving Average 200 Days2.75

Statistics

Average Volume2,344
Shares Outstanding46.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateJuly 18, 2014
AD